Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Corticosteriods linked with pneumonia admissions

  • Comment
Patients with COPD who are being prescribed inhaled corticosteroids have a 70% increased risk of being hospitalised for pneumonia, according to latest study findings.

Patients with COPD who are being prescribed inhaled corticosteroids have a 70% increased risk of being hospitalised for pneumonia, according to latest study findings.

Such patients also have a 53% increased relative risk of dying within 30 days of admission, research shows.

The figures come from a study of 175,906 patients with COPD in Canada, and follow secondary findings from another recently-published study on inhaled corticosteroids with a long-acting â-agonist.

Dr Mark Woodhead, consultant in general and respiratory medicine at Manchester Royal Infirmary, said: 'These observations cannot simply be dismissed.'

American Journal of Respiratory and Critical Care Medicine (2007) 176: 162-166

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.